search innovation
NEW PCR METHOD FOR DETECTION OF BACTERIA AND FUNGI IN BIOLOGICAL SAMPLE
keywords: sepsis, detection, bacteria, fungi, blood,
offer number: 192

The offer is a new PCR method for the simultaneous detection of bacteria and fungi in a sample of biological material. This technology allows simultaneous DNA detection of Gram-negative bacteria, Gram-positive bacteria, yeast fungi and molds in a sample of biological material, including patient’s spittle or blood.

 
Bacterial and fungal infections have always been a serious medical problem. Sepsis is the most dangerous systemic infection. Paradoxically, despite the development of medical knowledge and the introduction of new therapeutic procedures into the treatment, the incidence of sepsis is increasing. In the United States over 750 thousand people fall sepsis each year and it causes more than 215 thousand deaths. In the European Union there are more than 146 thousand deaths due to severe sepsis each year.
 
In the treatment of bloodstream infections the most important and difficult problem of determining the effectiveness of treatment and, consequently, the cost and time of hospitalization is the effective diagnosis of factors causing a systemic inflammatory response in sepsis. The material subjected to diagnostic testing is blood taken from a patient showing clinical signs of sepsis. The greatest difficulty is the very small amount of microorganisms being responsible for the infection in the blood, or they are only periodically seeded into the blood.
 
Currently, the standard diagnostic blood cultures are performed with specialized broth media, preferably in automatic culture systems. A weakness of these methods are time consumption (until a result of the study) and low sensitivity, which causes that in only 15-20% of the culture it is possible to achieve the growth of microorganisms. The situation is further complicated by the fact that patients undergo antibiotic treatment before a blood sample is taken for culture. In this case blood cultures are very difficult due to the fact that they contain antibiotics which inhibit the growth of microorganisms.
 
The molecular biology techniques, such as PCR or hybridization, belong to diagnostic methods that provide reliable, accurate and fast diagnosis of bloodstream infections. The sensitivity of molecular methods is much higher than the sensitivity of the culture method. However, currently available systems enable the detection of several particular species of microorganisms or every possible gene in theory, but on the other hand they require sequencing of PCR product, which
in turn increases the cost and time for the result.
 
The offered invention relates to a new method for detection of bacteria and fungi in a sample of biological material, in which the contained DNA is amplified by real-time multiplex PCR system. An amplification is carried out in two stages. In the first stage there are used primers specific for bacteria and fungi. Then the product of first amplification is used as a template in a second step – an amplification using primers and probes to differentiate yeast fungi and molds, Gram-positive
and Gram-negative bacteria.
 
The main advantages of the proposed method are:
  • detection of the entire panel of bacterial and fungal microorganisms, with the differentiation of Gram-negative bacteria, Gram-positive bacteria, yeasts fungi and molds, but without typing a particular species;
  • simultaneous amplification of at least two DNA sequences, which allows a simultaneous detection of bacteria and fungi, without waiting for the result of DNA electrophoresis;
  • application of a nested-PCR system which allows for increased sensitivity of detection by two orders of magnitude compared to one-stage PCR;
  • the possibility of using the detection method only for bacteria or fungi, or for the simultaneous detection of both fungi and bacteria, which reduces the cost of testing;
  • the opportunity to identify a specific species of microorganism after sequencing of the PCR product.
 
The offered method of detection of bacteria and fungi is patent pending. Further research and development of the invention are continued at the Department of Microbiology, Jagiellonian University Medical College. Currently the Centre for Technology Transfer CITTRU is looking for entities interested in commercial application of the invention.
commercial utility: diagnostics
field of science: medical biology, medicine
forms of protection: patent application
technological maturity: demanding R & D
property rights: Jagiellonian University
variants of cooperation: license, consulting, spin-off company, comercial contract research, sale

information / broker of Jagiellonian University

name and surname: Klaudia Polakowska, PhD
phone number: +48 12 664 42 13, +48 519 329 129
NEWS
latest information
JU scientists to develop biological agricultural support solutions
The project “Interactions between plants and microorganisms in response to the presence of potentially toxic metals, metalloids and silicon (Si)” by Prof. Katarzyna Turnau from the JU Faculty of Biology won a grant from the Polish National Agency for Academic Exchange. The study aimed at replacing the widespread use of agrochemicals with biological agricultural support solutions will also involve researchers from Slovakia and Austria.
JU students will help people suffering from depression
Therapify is a mobile application designed to help depressed people. It was first conceived by Łukasz Pstrong, a graduate of the AGH University of Science and Technology in Kraków, and developed over the course of the last two years with collaborators from his university, the Jagiellonian University, and SWPS University of Social Sciences and Humanities in Warsaw.
Plakaty Demo Day II +
In January, we complete the project managed by CTT CITTRU as part of the program of the Ministry of Science and Higher Education - Incubator of Innovation +. We supported, among others, 18 research teams selected in the competition, that develop innovative technologies. Thanks to the funds granted by CTT CITTRU and hard work of technology transfer officers, pre-implementation research was financed, which increased the attractiveness of these inventions and investors interest in them. Take look at the gallery of posters for technologies, developed as part of the project. What do you think about it
CITTRU team
Our employees
PARTNERS
Innovation Forum KrakówKlaster Lifescience KrakówWolves SummitPACTTJagiellońskie Centrum Innowacji
Contact
GET IN TOUCH WITH US
Centre for Technology Transfer CITTRU
Jagiellonian University in Kraków - POLAND
ul. Bobrzyńskiego 14,
30-348 Kraków

PHONE:
+48 12 664 42 00
E-MAIL:
cittru@uj.edu.pl
Fundusze EuropejskieMNiSWInkubator InnowacyjnościUnia Europejska